Showing results (541-550 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancerR K Oldham, M H Gail, M A Baker, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assayM Vilien, M Troye-Blomberg, P Perlmann, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomasI Berczi, V Holford-Strevens, Z H Warsi, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patientsR K Gupta, A M Leitch, D L MortonCancer Immunology, Immunotherapy : CII|January 1, 1983
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsW Den Otter, J W De Groot, H F DullensCancer Immunology, Immunotherapy : CII|January 1, 1983
Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activityK Kishida, Y Masuho, M Saito, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Immunochemotherapy of breast cancer with Propionibacterium granulosumK Roszkowski, B Nozdryn-Plotnicki, W Roszkowski, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinomaI Kimber, M Moore, A Howell, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Antibodies to tumour eluates react preferentially with non-lymphoid tumoursJ E Boyd, K JamesCancer Immunology, Immunotherapy : CII|January 1, 1983
Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growthS Ben-Efraim, R C Bocian, M B Mokyr, et al.Pageof 650